David Jack

4.4k total citations · 1 hit paper
112 papers, 3.2k citations indexed

About

David Jack is a scholar working on Pharmacology, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, David Jack has authored 112 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Analytical Chemistry and 13 papers in Molecular Biology. Recurrent topics in David Jack's work include Analytical Methods in Pharmaceuticals (13 papers), Analytical Chemistry and Chromatography (12 papers) and Pharmacological Effects and Assays (9 papers). David Jack is often cited by papers focused on Analytical Methods in Pharmaceuticals (13 papers), Analytical Chemistry and Chromatography (12 papers) and Pharmacological Effects and Assays (9 papers). David Jack collaborates with scholars based in United Kingdom, United States and Switzerland. David Jack's co-authors include Howard Poizner, Alma S. Merians, Grigore Burdea, Marilyn Tremaine, Rareș Boian, Michael Recce, R T Brittain, J B Farmer, S. V. Adamovich and Sergei V. Adamovich and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

David Jack

99 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Virtual reality-enhanced stroke rehabilitation

2001 545 citations David Jack, Rareș Boian et al. IEEE Transactions on Neural Systems and Rehabilitation Engineering profile →

Peers

Countries citing papers authored by David Jack

Since Specialization

Citations

This map shows the geographic impact of David Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jack more than expected).

Fields of papers citing papers by David Jack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jack. The network helps show where David Jack may publish in the future.

Co-authorship network of co-authors of David Jack

This figure shows the co-authorship network connecting the top 25 collaborators of David Jack. A scholar is included among the top collaborators of David Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jack. David Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A slope method for the determination of electron energy for quality assurance 2024 ·Journal of Applied Clinical Medical Physics ·(unknown), David Jack	1
2	Evaluation of infection concept and content integration in a baccalaureate nursing program curriculum 2021 ·American Journal of Infection Control ·David Jack, (unknown), Monika Pogorzelska‐Maziarz, Mary Lou Manning	2
3	Geology of the Enterprise Hydrothermal Nickel Deposit, North-Western Province, Zambia 2014 ·Economic Geology ·(unknown), (unknown), David Wood, Nigel M. Kelly, Gareth T. Williams, (unknown), Yvette D. Kuiper, David Jack, Holly J. Stein	27
4	Visuomotor learning in immersive 3D virtual reality in Parkinson’s disease and in aging 2006 ·Experimental Brain Research ·Julie Messier, Sergei Adamovich, David Jack, Wayne A. Hening, Jacob Sage, Howard Poizner	52
5	A bright future for osteoporosis treatment. 2005 ·PubMed ·David Jack	1
6	Virtual reality-enhanced stroke rehabilitation breakdown → 2001 ·IEEE Transactions on Neural Systems and Rehabilitation Engineering ·David Jack, Rareș Boian, Alma S. Merians, Marilyn Tremaine, Grigore Burdea, S. V. Adamovich, Michael Recce, Howard Poizner	545
7	One hundred years of aspirin 1997 ·The Lancet ·David Jack	145
8	Haptoglobin typing of bloodstains using horizontal discontinuous polyacrylamide gel electrophoresis 1995 ·Science & Justice ·(unknown), (unknown), (unknown), Robert C. Shaler, (unknown), David Jack	1
9	Keep takingthe tomatoes — the exciting world of nutraceuticals 1995 ·Molecular Medicine Today ·David Jack	14
10	Management of accounts receivable, 1. 1994 ·PubMed ·David Jack, (unknown)	0
11	Give a drug a bad name. 1991 ·BMJ ·David Jack, (unknown)	3
12	Salmeterol, a novel, long‐acting β₂‐adrenoceptor agonist: characterization of pharmacological activityin vitroandin vivo 1991 ·British Journal of Pharmacology ·D.I. Ball, R T Brittain, Robert A. Coleman, (unknown), David Jack, Malcolm Johnson, Lawrence H. C. Lunts, Anthony T. Nials, (unknown), I.F. Skidmore	163
13	Safety by Design 1990 ·Drug Safety ·David Jack	20
14	Measurement of the distribution coefficients of several classes of drug using reversed-phase thin-layer chromatography 1988 ·Journal of Chromatography A ·David Jack, (unknown), L. W. Rooney, (unknown), Jessica Lobo, (unknown)	5
15	THE PHARMACEUTICAL INDUSTRY IN THE U.S.S.R. 1987 ·Journal of Clinical Pharmacy and Therapeutics ·David Jack, (unknown)	1
16	A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium 1980 ·European Journal of Clinical Pharmacology ·J. V. Willis, M. J. Kendall, David Jack	39
17	Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), (unknown), (unknown), David Jack, (unknown), R. Stables	62
18	Sniffing syndrome. 1971 ·BMJ ·David Jack	14
19	Salbutamol: a new, selective β‐adrenoceptive receptor stimulant 1969 ·British Journal of Pharmacology ·(unknown), J B Farmer, David Jack, Gerhard Levy	247
20	A New Synthesis for 1-Aminohydantoin and Nitrofurantoin 1959 ·Journal of Pharmacy and Pharmacology ·David Jack	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact